Packaged film dosage unit containing a complexate
AssigneeMonosol Rx, LLC
InventorRichard C. Fuisz
Life of this patent
Estimating the term…
Abstract
The present invention relates to packaged orally consumable film dosage units for delivery of actives into the oral cavity. In particular, the packaged pharmaceutical product contains a complexate including a complexing agent and an active, an orally consumable film for delivery of the complexate and a package for containing the orally consumable film. The package includes indicia associated therewith. The indicia identifies the complexate as the active ingredient contained in the film, which is as a regulatory approvable chemical entity. The present invention also relates to methods of labeling, pricing, marketing and satisfying governmental regulations for such packaged pharmaceutical products.
Claims21
A packaged pharmaceutical product comprising:
- a taste-masked complexate comprising a complexing agent comprising an ion exchange resin and an active, wherein said ion exchange resin controls the release of said active and improves the stability of said active and wherein said complexate is a distinct chemical entity when compared to said active;
- an orally consumable film comprising said complexate, wherein the orally consumable film has mucoadhesive properties and a minimum dissolution time of at least a few minutes;
- and
- a package for containing said orally consumable film, said package comprising indicia associated therewith identifying said complexate as a regulatory approvable chemical entity.
A method of labeling a packaged pharmaceutical product in a manner that is consistent with governmental drug regulations, comprising the steps of:
- (a) providing a packaged pharmaceutical product comprising:
- (i) a taste-masked complexate comprising a complexing agent comprising an ion exchange resin and a pharmaceutical active, wherein said ion exchange resin controls the release of said active and improves the stability of said active and wherein said complexate is a distinct chemical entity when compared to said active;
- (ii) an orally consumable film comprising said complexate, wherein said orally consumable film has mucoadhesive properties and a minimum dissolution time of at least a few minutes;
- and
- (iii) a package for containing said orally consumable film;
- (b) adding indicia to said package, said indicia comprising a list of active ingredients contained in said orally consumable film and a list of inactive ingredients contained in said orally consumable film, wherein said complexate is listed as an active ingredient.
A method of disseminating accurate drug information to consumers of a packaged pharmaceutical product, comprising the steps of:
- (a) providing a packaged pharmaceutical product comprising:
- (i) a taste-masked complexate comprising a complexing agent comprising an ion exchange resin and a pharmaceutical active wherein said ion exchange resin controls the release of said active and improves the stability of said active and wherein said complexate is a distinct chemical entity when compared to said active;
- (ii) an orally consumable film comprising said complexate, wherein said orally consumable film has mucoadhesive properties and a minimum dissolution time of at least a few minutes;
- and
- (iii) a package for containing said orally consumable film;
- (b) providing indicia identifying the complexate as an active ingredient contained in the packaged pharmaceutical product;
- and
- (c) exposing consumers to the indicia, thereby providing accurate information as to the active ingredient contained in the packaged pharmaceutical product.
Dependencies are inferred from the claim text.